Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

9.73
-0.0500-0.51%
Pre-market: 9.48-0.2500-2.57%05:21 EDT
Volume:1.25M
Turnover:12.05M
Market Cap:848.04M
PE:-4.57
High:9.93
Open:9.86
Low:9.44
Close:9.78
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.95
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.97
PE(LYR):-5.20

Loading ...

Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report